Key Highlights
- ARK Invest offloaded 3,578 shares of Meta valued at approximately $2.1 million across three ETFs
- The investment firm dumped 95,090 Roku shares worth roughly $9.1 million from multiple funds
- ARK acquired 84,939 Tempus AI shares valued at approximately $4.1 million during Wednesday’s session
- Tempus AI now ranks as the third-biggest position in ARK Innovation ETF, representing about 5% of total assets
- Meta faced a courtroom defeat in a social media addiction lawsuit and announced layoffs affecting hundreds of employees
Cathie Wood’s investment management firm ARK Invest reduced its exposure to Meta and Roku during Wednesday’s trading session on March 25, reallocating capital toward healthcare artificial intelligence firm Tempus AI.
The firm disposed of 3,578 shares of Meta distributed across three separate funds. Calculated using Wednesday’s closing valuation, the transaction totaled approximately $2.1 million. ARK Innovation ETF currently maintains a position of about 105,000 Meta shares, valued near $63 million — representing roughly 1% of the fund’s total holdings.
Wednesday proved eventful for Meta on multiple fronts. A jury delivered a verdict finding both Meta and Google’s YouTube liable for negligence in operating platforms that caused harm to young users in a groundbreaking social media addiction lawsuit. Both technology giants announced intentions to appeal the decision.
Meta simultaneously announced an ambitious executive compensation structure targeting a 500% stock price appreciation and a $9 trillion market capitalization by 2031. The social media giant confirmed to Barron’s that workforce reductions affecting several hundred positions across sales, recruiting, and virtual reality departments were underway. Nevertheless, Meta’s stock price concluded trading Wednesday with a modest 0.3% gain.
ARK additionally liquidated 95,090 shares of Roku distributed among its ARKK, ARKW, and ARKF funds, representing approximately $9.1 million in total value. This transaction follows another substantial Roku divestment executed one day earlier on March 24.
Other divestments executed Wednesday included 30,174 Teradyne shares valued at roughly $9.7 million, plus 205,019 shares of Bullish spread across three ETFs totaling about $7.7 million. ARK has maintained a pattern of reducing its Bullish position throughout the previous week.
Supplementary sales encompassed 62,393 shares of Kratos Defense alongside 27,647 Natera shares, valued at $4.8 million and $5.4 million respectively.
ARK’s Substantial Tempus AI Investment
Regarding acquisitions, ARK’s primary transaction focused on Tempus AI. The investment firm purchased 84,939 shares distributed between its ARKK and ARKG ETFs, deploying approximately $4.1 million.
Tempus AI shares declined 4.2% during Wednesday’s session and have depreciated 21% year-to-date in 2026. ARK’s acquisition appears strategically timed as a value purchase during the price decline.
ARK Innovation ETF presently maintains approximately 6.3 million Tempus AI shares with a valuation exceeding $294 million. This positions it as the fund’s third-most significant holding, trailing only Tesla and Crispr Therapeutics, at approximately 5% of aggregate fund assets.
Systematic Portfolio Restructuring
ARK’s Wednesday transactions reveal a consistent strategic approach. The firm has systematically decreased positions in Roku, Teradyne, and Bullish across multiple consecutive trading days.
Concurrently, the investment manager has been expanding its Tempus AI allocation. Tempus AI operates as a healthcare technology enterprise leveraging artificial intelligence for medical data analysis and oncology treatment solutions.
Additional minor acquisitions executed Wednesday encompassed shares of Archer Aviation, Beam Therapeutics, and other portfolio companies.
The ARK Innovation ETF concluded Wednesday’s session with a 1.3% advance.
